Paper Details

  1. Home
  2. Paper Details

CDK 4/6 inhibitor induced lung injury: a case report and review of literature.

Author: AndrewsAnand George, JoelAnjana, JohnAjoy Oommen, MathewNamrata, SinghAshish

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Overview

Palbociclib, a CDK 4/6 inhibitor, is used for treating breast cancer. While common side effects include neutropenia, anemia, and fatigue, the drug has also been linked to pneumonitis, particularly in Asian populations. This case report highlights a patient who developed pneumonitis while on palbociclib and discusses potential mechanisms and management strategies for this potentially fatal complication.
Paper Details　
Original Abstract of the Article :
Palbociclib is a cyclin dependent kinase (CDK) 4/6 inhibitor that is indicated in combination with an aromatase inhibitor for first-line treatment of hormone receptor-positive, human epidermal growth factor receptor 2 -negative advanced or metastatic breast cancer. The commonly described side effect...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241445/

データ提供：米国国立医学図書館（NLM）

CDK 4/6 inhibitor induced lung injury: a case report and review of literature

This research delves into the complex world of cancer treatment and explores a potential side effect of a specific drug, palbociclib, a CDK 4/6 inhibitor used to treat breast cancer. Imagine a camel caravan crossing a desert, where a seemingly safe path might harbor unexpected dangers. This research examines a case report and reviews existing literature to investigate a potential complication associated with palbociclib, namely pneumonitis.

Navigating the potential risks of cancer treatments

This research highlights the importance of carefully monitoring patients undergoing treatment with palbociclib, particularly those of Asian descent. Just as a caravan leader must be vigilant for potential hazards in the desert, healthcare professionals must be aware of the potential risks associated with certain medications. This study underscores the need for a cautious approach to palbociclib treatment, given its potential to cause lung injury in certain individuals.

Ensuring patient safety and well-being

This research emphasizes the importance of patient safety and careful monitoring in cancer treatment. Imagine a camel caravan equipped with a vigilant guide who can swiftly respond to any challenges along the way. By acknowledging the potential risks and implementing appropriate preventive measures, we can ensure that patients receive safe and effective cancer treatments.

Dr.Camel's Conclusion

This research highlights the need for careful vigilance and proactive monitoring in cancer treatment. Just as a caravan leader navigates a desert landscape, ensuring the safety and well-being of their camels, healthcare professionals must be aware of potential risks and adapt treatment strategies accordingly.
Date :
  1. Date Completed n.d.
  2. Date Revised 2023-11-07
Further Info :

Pubmed ID

34267801

DOI: Digital Object Identifier

PMC8241445

Related Literature

Article Analysis
・Side Effects of palbociclib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.